Global Reporting Initiative

Tópicos materiais - Environment

Check out the quantitative data on Scope 1 emissions from RD Saúde. Information on Scopes 2 and 3 emissions can be verified in disclosure 305-2 and 305-3, respectively. Also check out qualitative information about our climate journey in disclosure 305-5. Notas após tabelas: 1. Includes Kyoto GHG emissions in tCO2e (CO2, CH4, N2O, SF6, HFCs and PFCs). Does not include CO2 emissions from renewable sources. Non-Kyoto GHG emissions: 1,790.49 tCO2 e. 2. The total GHG emission only considers Scope 2 market-based method. Scope 2 location-based totaled 27,853.36 tCO2e in 2021, 7,795.26 tCO2e in 2022 and 7,962.89 tCO2e in 2023. 3. In 2022, RD Saúde hired a specialized consultancy to support the improvement of the GHG emissions inventory, including a detailed Scope 3 screening process. As a result of this work, emissions increased significantly. 4. The 2021 GHG emissions data will be recalculated – based on the review carried out in 2022 – and audited again throughout 2024. The updated figures will be published in the company’s next Annual and Sustainability Report.

Emissão biogênica por escopo (tCO2e)1

	2021	2022	2023
Escopo 1	24.596,19	29.051,29	20.980,46
Escopo 2 (por localização)	27.853,36	7.795,26	7.962,89
Escopo 2 (por escolha de compra)	22.887,21	5.020,20	3.838,63
Escopo 3	1.546,20	553.206,93	561.951,33
Total	49.029,60	587.278,42	586.770,43

Emissão biogênica por escopo (tCO2e)1

	2021	2022	2023
Escopo 1	1.760,04	1.629,70	1.602,08
Escopo 2 (por localização)	–	–	–
Escopo 2 (por escolha de compra)	1.032,92	–	2.787,73
Escopo 3	240,96	8.650,36	7.093,38
Total	3.033,92	10.280,06	11.483,19